Technology behind commercial devices for blood glucose monitoring in diabetes management: A review

Download
  1. Get@NRC: Technology behind commercial devices for blood glucose monitoring in diabetes management: A review (Opens in a new window)
DOIResolve DOI: http://doi.org/10.1016/j.aca.2011.07.024
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for:
TypeArticle
Journal titleAnalytica Chimica Acta
ISSN0003-2670
Volume703
Issue2
Pages124136; # of pages: 13
SubjectBlood glucose monitoring; Diabetes management; Electron mediators; Future trends; Integral part; Interferences; Rapid response; Blood; Information management; Glucose; aniline derivative; ascorbic acid; bilirubin; cholesterol; dopamine; ferricyanide; ferrocene derivative; glucose; glucose dehydrogenase; glucose oxidase; hexamethylene diisocyanate; macrogol; nitrosoaniline; paracetamol; polysiloxane; polyurethan; pyrroloquinolinequinone; unclassified drug; uric acid; accuracy; amperometric biosensor; blood glucose meter; blood glucose monitoring; chemical structure; computer program; coulometry; diabetes mellitus; electronics; equipment design; glucose blood level; human; information processing; medical instrumentation; oxidation reduction potential; priority journal; reflectometry; reliability; sensitivity and specificity; short survey; technology; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus; Enzymes; Humans; Membranes, Artificial; Oxidation-Reduction
AbstractThe blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed. © 2011 Elsevier B.V.
Publication date
LanguageEnglish
AffiliationNational Research Council Canada (NRC-CNRC); NRC Biotechnology Research Institute (BRI-IRB)
Peer reviewedYes
NPARC number21271280
Export citationExport as RIS
Report a correctionReport a correction
Record identifier03c03dbb-01c1-47d8-bcbc-63d77d75c8ba
Record created2014-03-24
Record modified2016-05-09
Bookmark and share
  • Share this page with Facebook (Opens in a new window)
  • Share this page with Twitter (Opens in a new window)
  • Share this page with Google+ (Opens in a new window)
  • Share this page with Delicious (Opens in a new window)